When was The Protocol founded?

The Protocol was founded in 2025 and raised its 1st funding round 1 year after it was founded.

Where is The Protocol located?

The Protocol is headquartered in New York, United States.

Is The Protocol a funded company?

The Protocol is a funded company, having raised a total of $***** in its 1st and only funding round, a Series A round on Apr 14, 2026.

When was the latest funding round of The Protocol?

The Protocol's latest funding was a $***** Series A round on Apr 14, 2026, with participation from 0 investor. Its primary sector is Nutraceuticals Tech. In United States, the Nutraceuticals Tech sector has seen $160M in funding in 2026 to date.

Where does The Protocol rank among its competitors?

The Protocol ranks 8th amongst 23 active competitors, of which 7 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was The Protocol, which secured $6M in Apr, 2026.

Who are the top competitors of The Protocol?

The Protocol's top competitors include Nuritas, Brightseed and Akay Bioactives. Among them, The Protocol secured the most recent funding round in April, 2026.

The Protocol - 2026 Company Profile, Funding & Competitors

The Protocol is a series A company based in New York (United States), founded in 2025. It operates as a Provider of physician prescribed peptide protocols for health and wellness. The Protocol has raised $6M in funding. The company has 23 active competitors, including 7 funded and 1 that has exited. Its top competitors include companies like Nuritas, Brightseed and Akay Bioactives.

Company Details

Provider of physician prescribed peptide protocols for health and wellness. These programs involve the use of amino acid chains to support biological functions such as recovery, metabolism, and cellular repair. Licensed clinicians review health histories to determine appropriate protocols for individuals. The substances are compounded by pharmacies and delivered directly to individuals for self-administration. The process includes clinical oversight, ongoing support, and periodic adjustments to the protocols based on individual progress and health goals.

Website: theprotocole.com
Email ID: *****@theprotocole.com
Phone Number: +1 **********

Key Metrics

Founded Year

2025

Location

New York, United States

Stage

Series A

Total Funding

$6M in 1 round

Latest Funding Round

Series A, Apr 14, 2026, $*****

Ranked

8^th among 23 active competitors

Similar Companies

Nuritas & 23 more

View The Protocol's full profile

The Protocol has raised a total funding of $6M over 1 round.

Here is the list of recent funding rounds of The Protocol:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 14, 2026	2591913	Series A	4193377	1486264	1933925	7144870

Access funding benchmarks and valuations. Sign up today!

View details of The Protocol's funding rounds and investors

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of The Protocol include Nuritas, Brightseed and Akay Bioactives. Here is the list of Top 10 competitors of The Protocol, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Nuritas 2014, Dublin (Ireland), Series C	Developer of natural active ingredients with scientifically proven health benefits	$113M	Cultivian Sandbox, THRIVE & 46 others	63/100
2nd	Brightseed 2018, San Francisco (United States), Series B	Provider of AI based platform to discover plant bio actives for human health	$120M	Temasek, Fifty Years & 14 others	63/100
3rd	Akay Bioactives 2008, Sayreville (United States), Unfunded	Provider of bioactive extracts to support health and wellness	-	-	35/100
4th	Lembas 2024, Tel Aviv (Israel), Seed	Developer of functional ingredients for weight management in food products	$3.6M	FLORA Ventures, SDH Ventures & 6 others	29/100
5th	BioCell Technology 1997, Newport Beach (United States), Unfunded	Innovating science-backed branded ingredients for health, wellness, and beauty	-	-	29/100
6th	Sterling Technology 1980, Brookings (United States), Acquired	Developer of nutritional bioactive protein products for veterinary and human use	-	-	27/100
7th	Fuyingguan 2021, Qinhuangdao (China), Series A	Manufacturer of nutritional supplements and food products	$4.12M	Huatai Securities	27/100
8th	The Protocol 2025, New York (United States), Series A	Provider of physician prescribed peptide protocols for health and wellness	$6M	-	25/100
9th	Eclipse Ingredients 2024, Brisbane (Australia), Series A	Developer of human lactoferrin using precision fermentation for health applications	$4.59M	AgFunder, Faba	25/100
10th	Pure Cultures 2013, Denver (United States), Seed	-	$400K	IndieBio	25/100